Alzheimeri tõve geneetikast ja patofüsioloogiast
1183-1188.
9. Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC.1998.
Molecular mapping of Alzheimer-type dementia in Down's syndrome. Annals of neurology
43(3), 380-383.
10. Mahley RW, Weisgraber KH, Huang Y. 2006. Apolipoprotein E4: a causative factor and
therapeutic target in neuropathology, including Alzheimer's disease. Proceedings of the
National Academy of Sciences of the United States of America 103(15):5644-5651.
11. Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease. The Lancet 368(9533),
387-403.
12. Verghese PB, Castellano JM, Holtzman DM. 2011. Apolipoprotein E in Alzheimer's
disease and other neurological disorders. Lancet Neurology 10(3), 241-252.
annaabi.ee 
